CD8A and neoplasm: MDSCs obstruct T-cell activation and promote angiogenesis, while TAMs, particularly those exhibiting an M2-like phenotype, aid in tumor progression by remodeling the extracellular matrix and suppressing CD8 + T-cell responses [33].